The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Eisai; Medac; Merck Serono; Novartis; Roche Pharma AG; Sanofi; SERVIER; Shire
Consulting or Advisory Role - Amgen; Roche Pharma AG; Shire; Teva
Travel, Accommodations, Expenses - Ipsen; Medac; Merck Serono; PharmaMar
Surgical and pathological outcome, and pathological regression, in patients receiving perioperative atezolizumab in combination with FLOT chemotherapy versus FLOT alone for resectable esophagogastric adenocarcinoma: Interim results from DANTE, a randomized, multicenter, phase IIb trial of the FLOT-AIO German Gastric Cancer Group and Swiss SAKK.
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Institut für Klinische Krebsforschung GmbH
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Lilly; MacroGenics; Merck Sharp & Dohme
Speakers' Bureau - AIO gGmbH; Bristol-Myers Squibb; Lilly; MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Immutep; Ipsen; Lilly; Medac; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma
 
Sylvie Lorenzen
No Relationships to Disclose
 
Peter C. Thuss-Patience
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Meyers-Squibb; Daiichi Sankyo; Lilly; Merck KGaA; Merck Serono; Novartis; Pfizer; Roche
Research Funding - Merck/Pfizer (Inst)
 
Nils Homann
Consulting or Advisory Role - Amgen; BMS GmbH & Co. KG; Lilly; MSD Oncology; SERVIER
 
Michael Schenk
No Relationships to Disclose
 
Udo Lindig
No Relationships to Disclose
 
Vera Heuer
No Relationships to Disclose
 
Albrecht Kretzschmar
No Relationships to Disclose
 
Eray Goekkurt
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pfizer; Roche Pharma AG; Sanofi; SERVIER
Travel, Accommodations, Expenses - SERVIER
 
Georg Martin Haag
Honoraria - Bristol-Myers Squibb; iOMEDICO; Lilly; MSD Oncology; SERVIER; Targos GmbH
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Lilly; MSD Oncology (Inst); Novartis
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); MSD Oncology (Inst); Nordic Group (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Inst); Lilly (Inst); MSD Oncology; SERVIER
 
Jorge Riera Knorrenschild
No Relationships to Disclose
 
Claus Bolling
Research Funding - MOLOGEN; PledPharma
 
Ralf-Dieter Hofheinz
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Medac; Merck Serono; MSD; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - German Cancer Aid (Inst); Medac (Inst); Sanofi (Inst)
 
Stefan Angermeier
No Relationships to Disclose
 
Thomas Jens Ettrich
Consulting or Advisory Role - AstraZeneca; Bayer; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Incyte; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen
 
Alexander Siebenhuener
No Relationships to Disclose
 
Christina Kopp
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Foundation Medicine; Incyte; Lilly; MSD Oncology; Novartis; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - AstraZeneca (Inst); Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe (Inst); Gemeinsamer Bundesausschuss; Incyte (Inst); Lilly (Inst)
 
Timo Gaiser
Leadership - Reprognostics
Honoraria - Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche